echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Rheumatology: application experience of mycophenolate mofetil in adolescent idiopathic inflammatory myopathy

    Rheumatology: application experience of mycophenolate mofetil in adolescent idiopathic inflammatory myopathy

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: To evaluate the efficacy and safety of mycophenolate mofetil (MMF) in the treatment of juvenile idiopathic inflammatory myopathy (JIIM.


    Methods: Patients diagnosed with JIIM and treated with MMF at the Juvenile Dermatomyositis Study Group (JDRG) in the United Kingdom or the Giannina Gaslini Institute in Genoa, Italy were included in the stud.


    The following information was collected retrospectively at MMF initiation, 3, 6, 12 months after treatment initiation and at last follow-up: clinical presentation, laboratory data, physician's subjective assessment of disease activity, standardized outcome measures of muscle strength/endurance , skin disease activity, physical function, overall disease activity, cumulative damage, and ongoing treatmen.


    Results: Of the 29 patients, 23 had juvenile dermatomyositis and 6 had overlapping myositi.


    The number of patients without active disease increased from 13% at baseline to 65% at last follow-u.


    Conclusions: This study demonstrates that MMF is a valuable therapeutic option for the management of JII.


    Source:

    Varnier GC, Consolaro A, Cheng IL, et a.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.